journal article·2017-03-13

Controlled Release of Usnic Acid from Biodegradable Polyesters to Inhibit Biofilm Formation

Queeny Dasgupta, Giridhar Madras, Kaushik Chatterjee

Publisher page

Abstract

Controlled and sustained release of antibacterial drugs is a promising approach to address challenges related to bacterial infections in biomedical implants. Biocompatible polyols like xylitol and mannitol are frequently used to synthesize cross-linked, biodegradable polyesters. Xylitol-based adipoyl and sebacoyl polyesters were synthesized by a catalyst free melt polyesterification technique. Unlike traditional drug delivery systems, the objective of this work was to develop biodegradable polymers with usnic acid (UA), a known antibacterial agent, entrapped in the polymer network. Apart from offering a wider control of the release kinetics and improved processability, the hydrolytic degradation results in the concomitant resorption of the polymer. Polymer properties such as degradation, modulus, and drug release were tuned through a subtle change in the chain length of the diacid. In 1 week, the xylitol based adipoyl ester degrades 41% and releases 25% of its initial drug loading whereas the sebacoyl ester degrades 23% in and releases 9% of the loaded drug. A kinetic model has been used to understand the UA release profiles and determine degradation and release parameters that influence release from the polymers. These polyesters are cytocompatible and exhibit excellent bactericidal activity against Staphyloccus aureus by inducing oxidative stress. This work enables a strategy to synthesize biodegradable polymers for potential to inhibit biofilm formation in vivo with tunable mechanical and degradation properties, and variable controlled release.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Antimicrobial agents and applications · Pharmaceutical and Antibiotic Environmental Impacts · Orthopedic Infections and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Centre for Biosystems Science and Engineering, ‡Department of Chemical Engineering, and §Department of Materials Engineering, Indian Institute of Science, Bangalore 560012, India

Funding

Department of Biotechnology , Ministry of Science and Technology · Department of Science and Technology, Ministry of Science and Technology

References (35)

Show source-provided references
1. Report on the Burden of Endemic Health Care-Associated Infection Worldwide;World Health Organization:Geneva, Switzerland, 2011.
2. 10.1016/S0140-6736(10)61458-410.1016/S0140-6736(10)61458-4 ↗
3. 10.1016/j.ijmm.2004.06.01510.1016/j.ijmm.2004.06.015 ↗
4. 10.22203/eCM.v008a0510.22203/eCM.v008a05 ↗
5. 10.1016/j.injury.2006.04.00310.1016/j.injury.2006.04.003 ↗
6. 10.1016/j.biomaterials.2012.05.03110.1016/j.biomaterials.2012.05.031 ↗
7. 10.1080/08927014.2013.84885810.1080/08927014.2013.848858 ↗
8. 10.1128/AAC.48.11.4360-4365.200410.1128/AAC.48.11.4360-4365.2004 ↗
9. 10.1515/znc-2004-5-61710.1515/znc-2004-5-617 ↗
10. 10.5897/AJB11.355110.5897/AJB11.3551 ↗
11. 10.1016/j.micres.2015.06.00910.1016/j.micres.2015.06.009 ↗
12. 10.1097/01.cad.0000175588.09070.7710.1097/01.cad.0000175588.09070.77 ↗
13. 10.1007/s10456-012-9270-410.1007/s10456-012-9270-4 ↗
14. 10.1155/2011/76159310.1155/2011/761593 ↗
15. 10.1016/j.ijpharm.2013.08.02610.1016/j.ijpharm.2013.08.026 ↗
16. 10.1016/S0014-827X(98)00113-X10.1016/S0014-827X(98)00113-X ↗
17. 10.1080/14786419.2015.100745510.1080/14786419.2015.1007455 ↗
18. 10.1016/j.ejpb.2006.05.01810.1016/j.ejpb.2006.05.018 ↗
19. 10.1016/j.ejpb.2014.06.00210.1016/j.ejpb.2014.06.002 ↗
20. 10.1016/j.apsusc.2013.09.08110.1016/j.apsusc.2013.09.081 ↗
21. 10.1016/j.reactfunctpolym.2014.07.00210.1016/j.reactfunctpolym.2014.07.002 ↗
22. 10.1109/TNB.2011.217826310.1109/TNB.2011.2178263 ↗
23. 10.1007/s11051-013-1766-310.1007/s11051-013-1766-3 ↗
24. 10.1080/0265204041000167391910.1080/02652040410001673919 ↗
25. 10.1039/C5BM00051C10.1039/C5BM00051C ↗
26. 10.1021/bm501302510.1021/bm5013025 ↗
27. 10.1021/acs.molpharmaceut.5b0051510.1021/acs.molpharmaceut.5b00515 ↗
28. 10.1002/adma.20070208810.1002/adma.200702088 ↗
29. 10.1016/S0031-9422(02)00383-710.1016/S0031-9422(02)00383-7 ↗
30. 10.1002/9780470027318.a560610.1002/9780470027318.a5606 ↗
31. 10.1016/j.bmc.2008.05.06910.1016/j.bmc.2008.05.069 ↗
32. 10.1016/S0367-326X(98)00033-110.1016/S0367-326X(98)00033-1 ↗
33. 10.1080/03602559.2011.59308210.1080/03602559.2011.593082 ↗
34. Brannon-Peppas L. · 2012
35. 10.1039/B610522J10.1039/B610522J ↗